Does the menopause increase your risk of heart disease?

Posted on September 26, 2023 by Sally-Anne Turner

The menopause is often seen as a private matter, and many women feel it is stigmatised in the workforce and throughout society. This cultural silence around menopause has created significant barriers to open discussion, leaving countless women struggling alone with symptoms that can dramatically impact their daily lives. In professional settings, women frequently report feeling unable to discuss their menopausal symptoms with managers or colleagues, fearing it might affect their career progression or how they're perceived in the workplace. This stigma extends beyond the office, with many women finding it difficult to talk about menopause even with close friends and family members.

Due to this widespread stigmatisation and the historical tendency to dismiss women's health concerns, research into the menopause and its symptoms, knock-on effects, and the impact it has on wider health implications isn't investigated as thoroughly as we'd like. For decades, menopause was viewed simply as the end of reproductive capability rather than a significant life transition with far-reaching health implications. The medical community has historically underfunded research into women's health conditions, and menopause has been particularly neglected. This research gap means that many women and even healthcare professionals aren't fully aware of the serious health risks associated with menopause, including the significantly increased risk of cardiovascular disease.

The lack of comprehensive research has real-world consequences. Women going through menopause often don't receive adequate information about the changes happening in their bodies or the potential health risks they face. Many are unaware that the hormonal changes of menopause can affect their heart health, bone density, metabolic function, and mental wellbeing in profound ways. Without this knowledge, women cannot make informed decisions about their health or seek appropriate preventative treatments that could protect them from serious conditions like heart disease and stroke.

Here at Bodyline throughout Menopause Month, we'd like to spread awareness of the impact that menopause has on women and their general health and wellbeing, including by increasing their risk of heart disease. As a CQC-regulated medical wellness clinic with over 18 years of experience supporting more than 100,000 patients across the UK, we've witnessed firsthand how transformative proper menopause care can be. Our specialist menopause nurses and clinicians have dedicated their careers to helping women navigate this challenging life stage with expert medical support, personalised treatment plans, and compassionate care.

At Bodyline, we believe that every woman deserves to understand the changes happening in her body and to have access to safe, effective treatments that can protect her long-term health. Our comprehensive approach to menopause care goes beyond simply managing symptoms – we focus on identifying and mitigating the serious health risks associated with hormonal changes, including cardiovascular disease, osteoporosis, and metabolic disorders. Through our bespoke M Plan treatment programmes, we provide women with the knowledge, support, and medical interventions they need to thrive during and after menopause.

What is the menopause?

The menopause happens at the end of a woman's reproductive life, when a change in hormone levels means she is unable to have children or menstruate any longer. Technically, menopause is defined as the point when a woman hasn't had a menstrual period for twelve consecutive months. However, the transition to menopause – known as perimenopause – typically begins several years before the final period, with most women experiencing this transition in their late forties or early fifties. The average age of menopause in the UK is 51 years old, though it can occur naturally anywhere between the ages of 45 and 55.

These hormonal changes can cause several symptoms that vary dramatically from woman to woman, making menopause a highly individual experience. Some women sail through menopause with minimal disruption to their lives, experiencing only mild symptoms that don't significantly impact their daily activities. However, for many women, the reality is far more challenging. Research indicates that approximately 75% of women experience noticeable menopausal symptoms, with around 25% describing their symptoms as severe enough to significantly affect their quality of life, work performance, and relationships.

The hormonal changes of menopause occur because the ovaries gradually produce less oestrogen and progesterone, the primary female sex hormones. These hormones have been regulating the menstrual cycle since puberty, but they also play crucial roles throughout the body. Oestrogen, in particular, affects the brain, bones, skin, cardiovascular system, and many other tissues. When oestrogen levels decline during menopause, the effects ripple throughout the entire body, which is why menopausal symptoms are so varied and can affect multiple body systems simultaneously.

Without the necessary resources, support, and education, menopausal women may face challenges due to debilitating symptoms and health risks associated with menopause. Many women struggle for years without proper diagnosis or treatment, often because they don't recognise their symptoms as being related to menopause or because they've been told that their symptoms are simply something they must endure. This lack of support can lead to unnecessary suffering, reduced quality of life, and missed opportunities for preventative health interventions that could protect against serious conditions like cardiovascular disease and osteoporosis.

A survey conducted by the House of Commons' Women and Equalities Committee found that the most common menopausal symptoms reported by women include difficulty sleeping, problems with memory and concentration, hot flashes, night sweats, anxiety, and depression. These symptoms significantly impact women's ability to concentrate, increase stress levels, and reduce confidence, with 31% of respondents needing to take time off work due to their symptoms. The survey revealed the profound economic and social impact of untreated menopausal symptoms, with many women reporting that they had considered leaving their jobs or had actually left employment because they couldn't manage their symptoms while working.

Beyond these commonly recognised symptoms, menopause can also cause joint pain, headaches, heart palpitations, mood swings, reduced libido, vaginal dryness, urinary problems, and changes in skin and hair quality. The psychological impact can be particularly distressing, with many women experiencing a loss of confidence, feelings of not being themselves, and concerns about their identity and purpose as they transition out of their reproductive years. These emotional and psychological symptoms are just as valid and important as physical symptoms, yet they're often overlooked or dismissed.

The duration and severity of menopausal symptoms vary considerably between individuals. Some women experience symptoms for just a few months, while others may struggle with them for a decade or longer. Research suggests that the average duration of menopausal symptoms is around seven years, though approximately 10% of women continue to experience symptoms well into their sixties and beyond. This prolonged symptom duration means that menopause isn't simply a brief transition but rather a significant life stage that deserves proper medical attention and support.

Contact Bodyline today to find out more about our hormone replacement therapy services

Is heart disease linked to menopause?

The impact of menopause on women's health goes beyond symptoms alone. Menopause also increases the risk of cardiovascular diseases such as heart disease, strokes, and high blood pressure. This connection between menopause and cardiovascular health is one of the most significant yet least discussed aspects of this life transition. Many women are completely unaware that going through menopause fundamentally changes their cardiovascular risk profile, often quite dramatically. Before menopause, women generally enjoy a degree of protection against heart disease compared to men of the same age, but this protective advantage diminishes rapidly after menopause.

Cardiovascular disease is a leading cause of premature death in both men and women and has been quoted in 20% of all female deaths. In the UK, cardiovascular disease kills more than twice as many women as breast cancer, yet awareness of this risk remains surprisingly low among women themselves. Many women perceive breast cancer as their primary health threat and are unaware that heart disease poses a far greater statistical risk, particularly after menopause. This knowledge gap means that women may not take appropriate preventative measures during and after their menopausal transition, missing a critical window for cardiovascular risk reduction.

Menopause and cardiovascular disease are closely linked, posing a dangerous risk to the health and productivity of women in the UK workforce. The timing of menopause often coincides with women reaching senior positions in their careers, taking on caring responsibilities for ageing parents, and navigating other significant life changes. The combination of increased cardiovascular risk with these life stressors can create a perfect storm for heart health problems. Women who experience early menopause (before age 45) or premature menopause (before age 40) face even higher cardiovascular risks, with some studies suggesting their risk of heart disease may be doubled compared to women who experience menopause at the average age.

The British Heart Foundation reports that prior to menopause, women generally have a lower risk of cardiovascular heart disease. But once a woman has been through menopause, that is, once it has been one year since her last period, the risk of heart disease rises. This rise in risk isn't gradual – it can be quite sudden and significant. Research has shown that the incidence of cardiovascular events increases substantially in the years immediately following menopause, with the risk continuing to climb as women age. Within ten years after menopause, a woman's cardiovascular risk profile can look very different from what it was during her reproductive years.

The relationship between menopause and heart disease is multifaceted and involves changes in cholesterol levels, blood pressure, blood vessel function, body composition, and metabolic health. Studies have found that postmenopausal women often experience increases in total cholesterol, LDL (bad) cholesterol, and triglycerides, while their HDL (good) cholesterol may decrease. These lipid profile changes directly contribute to increased atherosclerosis risk – the buildup of fatty deposits in the arteries that can lead to heart attacks and strokes. Additionally, blood pressure tends to rise after menopause, with many women developing hypertension for the first time in their fifties or sixties.

Understanding this connection between menopause and cardiovascular disease is crucial for women's health. It means that menopause should be viewed not just as a reproductive transition but as a critical period for cardiovascular risk assessment and intervention. Women going through menopause should have their cardiovascular risk factors evaluated, including blood pressure, cholesterol levels, blood sugar, and body composition. This is an ideal time to implement preventative strategies, whether through lifestyle modifications, medical treatments like HRT, or other cardiovascular protective measures.

Why does risk of heart disease increase after the menopause?

The menopause is triggered when levels of the female hormones like estrogen and progesterone fluctuate and drop drastically, eventually stopping reproductive functions in the body. As a result, a woman no longer has periods or the ability to conceive. This hormonal decline doesn't happen overnight but typically occurs gradually over several years during perimenopause, with increasingly erratic hormone levels before finally settling at the low postmenopausal levels. During this transition, women may experience dramatic hormonal fluctuations, with oestrogen levels sometimes spiking before eventually declining, which can make symptoms particularly unpredictable and challenging to manage.

However, estrogen has other benefits in the body far beyond its reproductive functions. Estrogen helps keep arteries open and relaxed, preventing cholesterol from building up and potentially leading to blockages, which then increase the potential for heart attacks or strokes. Oestrogen acts as a natural vasodilator, helping blood vessels remain flexible and responsive to the body's changing needs. It also has anti-inflammatory properties that protect the cardiovascular system and helps maintain the health of the endothelium – the thin layer of cells lining the blood vessels that plays a crucial role in cardiovascular health.

When estrogen levels decrease during menopause, the risk of fat accumulation in arteries increases, raising the risk of cardiovascular problems. Without adequate oestrogen, the arteries can become stiffer and less able to dilate properly in response to increased blood flow demands. This arterial stiffness is a significant risk factor for hypertension and cardiovascular events. The loss of oestrogen's protective effects also means that inflammatory processes in the blood vessels may increase, accelerating the development of atherosclerotic plaques. These plaques can narrow the arteries, restrict blood flow, and potentially rupture, causing blood clots that lead to heart attacks or strokes.

Additionally, hormones decreasing through the menopause cause women to get excess abdominal fat and make it much harder for them to lose it. This shift in body composition is one of the most frustrating aspects of menopause for many women. Even women who have maintained a stable weight throughout their lives often notice that fat redistributes to their midsection during menopause, creating the characteristic "menopause belly" that can be resistant to diet and exercise efforts. This isn't simply a cosmetic concern – it represents a genuine shift in metabolic health with serious implications for cardiovascular risk.

Abdominal fat increases waist size, and waist size is a commonly recognised indicator of heart disease risk. Specifically, visceral fat – the deep abdominal fat that surrounds the internal organs – is particularly problematic from a cardiovascular perspective. Unlike subcutaneous fat (the fat just under the skin), visceral fat is metabolically active and produces inflammatory substances and hormones that can negatively affect cardiovascular health, insulin sensitivity, and metabolic function. Research has consistently shown that increased waist circumference is associated with higher rates of heart disease, stroke, type 2 diabetes, and premature death.

Larger waist sizes mean a larger risk of heart attack and stroke. For women, a waist circumference of more than 80cm (about 31.5 inches) is considered to indicate increased health risks, while a waist circumference of more than 88cm (about 34.6 inches) indicates substantially increased risk. These measurements are important screening tools that can help identify women who would benefit from cardiovascular risk reduction strategies. The accumulation of visceral fat after menopause is driven partly by declining oestrogen levels but also by changes in insulin sensitivity, metabolic rate, and other hormonal factors.

Beyond the direct effects of oestrogen loss, menopause also affects other aspects of cardiovascular health. Many women experience changes in their lipid profile, with increases in total cholesterol and LDL cholesterol and decreases in HDL cholesterol. Blood sugar control may worsen, with some women developing insulin resistance or type 2 diabetes after menopause. Blood pressure often rises, partly due to changes in blood vessel function and partly due to other factors like weight gain and increased stress. Sleep disturbances, which are extremely common during menopause, can also negatively impact cardiovascular health, as poor sleep is associated with increased blood pressure, inflammation, and cardiovascular risk.

The metabolic changes of menopause create what's sometimes called "metabolic syndrome" – a cluster of conditions including increased blood pressure, high blood sugar, excess abdominal fat, and abnormal cholesterol levels that together significantly increase cardiovascular disease risk. Research suggests that the prevalence of metabolic syndrome increases substantially after menopause, affecting as many as 40-60% of postmenopausal women in some populations. Recognising and addressing these metabolic changes is crucial for protecting cardiovascular health during and after the menopausal transition.

Can HRT help reduce the risk of heart disease?

Recent studies have shown that short-term use of hormonal replacement therapy (HRT) in menopausal women not only reduces symptom severity but also decreases the risk of heart and cardiovascular disease. This represents a significant shift in our understanding of HRT and cardiovascular health. For many years, there was confusion and concern about whether HRT increased or decreased cardiovascular risk, partly due to how certain influential studies were designed and interpreted. However, more recent research and reanalysis of existing data has provided clearer guidance about when and how HRT can be beneficial for cardiovascular health.

HRT is a treatment that replaces hormones depleted during menopause, such as estrogen and progesterone, which play a vital role in cardiovascular health. By restoring hormone levels closer to premenopausal levels, HRT can help maintain the cardiovascular protective effects that oestrogen provides. The cardiovascular benefits of HRT appear to be most significant when treatment is started during perimenopause or within the first few years after menopause – what's known as the "window of opportunity" or "timing hypothesis." Women who start HRT during this window may experience reduced cardiovascular risk compared to those who never use HRT or who start it many years after menopause.

The cardiovascular benefits of HRT include improved lipid profiles, with increases in HDL (good) cholesterol and decreases in LDL (bad) cholesterol and total cholesterol. HRT also helps maintain blood vessel flexibility and function, reducing arterial stiffness and improving the ability of blood vessels to dilate appropriately. These effects can help lower blood pressure and improve overall cardiovascular function. Additionally, HRT may have beneficial effects on insulin sensitivity and blood sugar control, which are important factors in cardiovascular health and metabolic syndrome prevention.

In addition to its cardiovascular benefits, HRT can also help manage other menopausal symptoms that contribute to an increased risk of cardiovascular disease, such as increased visceral fat, difficulties with sleeping, and cholesterol levels. The relief of menopausal symptoms can also have indirect cardiovascular benefits. For example, better sleep quality can help regulate blood pressure and reduce inflammation. Reduced hot flashes and night sweats can decrease the stress response and improve overall wellbeing. Relief from anxiety and depression can encourage healthier lifestyle choices and better adherence to cardiovascular protective behaviours like regular exercise and healthy eating.

By addressing the root cause of cardiovascular disease risk in menopausal women, HRT has the potential to improve their overall health and well-being. It can alleviate symptom severity, reduce stress levels, and enable women to enjoy their lives without the burden of menopausal symptoms. Women on appropriate HRT often report feeling more like themselves again, with improved energy, mood, cognitive function, and quality of life. This improved wellbeing can translate into better self-care, including maintaining a healthy diet, staying physically active, managing stress effectively, and keeping up with preventative health screenings.

It's important to note that HRT isn't suitable for everyone, and the decision to use HRT should be made on an individual basis after thorough discussion with a qualified healthcare professional. Women with certain medical histories, such as previous breast cancer, blood clots, or cardiovascular disease, may not be suitable candidates for HRT or may require modified treatment approaches. The type of HRT, the dose, the route of administration (pills, patches, gels, etc.), and the duration of treatment should all be tailored to the individual woman's needs, risk factors, and preferences.

At Bodyline, our specialist menopause clinicians take a comprehensive approach to HRT prescribing. We don't simply offer a standard HRT prescription – we conduct thorough blood tests to assess your individual hormone levels, evaluate your cardiovascular risk factors, discuss your symptoms and health goals, and create a bespoke treatment plan designed specifically for you. Our M Plan approach ensures that your HRT is optimised for your unique physiology and adjusted over time as your needs change. This personalised approach maximises the benefits of HRT while minimising potential risks.

Can I get HRT with Bodyline?

At Bodyline, we offer health and wellness solutions for menopausal women aiming to improve their quality of life, defy cardiovascular disease risk, and remain in the workforce. Our approach to menopause care is comprehensive, evidence-based, and centred on your individual needs. We understand that every woman's experience of menopause is unique, and we believe that your treatment should be equally personalised. Our gold standard menopause treatments like bespoke and personalised HRT can help women around the country, whether you visit one of our seven clinic locations across the Northwest of England or access our services through convenient online consultations available UK-wide.

Our range of treatments are tailored to your blood profile results and personal symptoms ensuring improved health and wellbeing. When you choose Bodyline for your menopause care, your journey begins with comprehensive blood testing that evaluates your hormone levels, including oestrogen, progesterone, testosterone, FSH, and other relevant markers. We also assess other health indicators that affect your overall wellbeing and cardiovascular risk, including thyroid function, vitamin D levels, cholesterol, and blood sugar. This detailed picture of your hormonal and metabolic health allows our clinicians to design a treatment plan that addresses your specific imbalances and health concerns.

Bodyline has over 17 years of treating and supporting over 100,000 patients to achieve their wellness goals, so you can be sure that you are in the best hands throughout your HRT journey. Our team includes experienced menopause specialist nurses and clinicians who have dedicated their careers to women's health. We're proud to be CQC-regulated, which means our services meet the highest standards of safety, effectiveness, and patient care. Our clinics in Birkenhead, Liverpool, Manchester, St Helens, Stockport, Stoke-on-Trent, and Warrington provide welcoming, professional environments where you can discuss your symptoms openly and receive expert care.

The Bodyline M Plan is more than just an HRT prescription – it's a complete menopause wellness programme. Your M Plan includes initial consultation and assessment, comprehensive blood testing and hormone profiling, bespoke HRT prescriptions tailored to your individual needs, ongoing monitoring and dose adjustments, regular follow-up appointments with your dedicated nurse, nutritional and lifestyle guidance to support your overall health, and access to our patient support resources. We also provide education about menopause and its health implications, helping you understand the changes happening in your body and empowering you to make informed decisions about your health.

Our HRT prescriptions can include various forms of oestrogen replacement (patches, gels, tablets), progesterone (if you still have your uterus), and testosterone if appropriate for your symptoms and hormone levels. We carefully consider the most suitable type and route of administration for your individual circumstances, taking into account factors like your cardiovascular risk profile, personal preferences, and how well you tolerate different formulations. Our goal is to find the HRT regimen that provides optimal symptom relief and health benefits with minimal side effects.

Beyond HRT, we also offer complementary treatments and support for other aspects of menopausal health. If you're struggling with weight gain or metabolic changes during menopause, we can provide medical weight loss support through our evidence-based weight management programmes. If sleep disturbances are a major concern, we can offer guidance and, where appropriate, treatments to improve sleep quality. Our holistic approach recognises that menopause affects multiple aspects of health and that optimal care addresses all these dimensions.

Many women worry about the safety of HRT, particularly regarding cardiovascular health, breast cancer risk, and other potential concerns. At Bodyline, we take these concerns seriously and provide clear, evidence-based information to help you make informed decisions. We'll discuss your individual risk factors, the potential benefits and risks of HRT for your specific situation, and alternative options if HRT isn't suitable or if you prefer not to use it. Our approach is always to support your autonomy and ensure you feel confident and comfortable with your treatment plan.

If you're interested in our complete bespoke clinically supported menopause treatment plan, the M Plan, please contact Bodyline today at 0800 995 6036 or by filling in our online contact form for a call back. Our friendly customer service team can answer your initial questions, explain how our services work, and book you in for your first consultation. Whether you're just beginning to experience menopausal symptoms, you're struggling with severe symptoms that are affecting your quality of life, or you're concerned about the long-term health implications of menopause including cardiovascular disease risk, we're here to help.

Taking control of your menopausal health is one of the most important things you can do for your long-term wellbeing. The menopausal transition is a critical window for cardiovascular risk assessment and intervention. By seeking appropriate treatment and support during this time, you can not only alleviate troublesome symptoms but also potentially reduce your risk of serious health conditions like heart disease and stroke. Don't let stigma or lack of information prevent you from accessing the care you deserve. Book a consultation at Bodyline Clinic to discuss how our personalised HRT programmes can help protect your heart health and improve your quality of life during menopause and beyond.

Our clinics are conveniently located across the Northwest, with Bodyline locations in major cities and towns to serve you better. If visiting a clinic isn't convenient for you, our online consultation service brings expert menopause care to your home, with the same high standards of clinical excellence and personalised treatment planning. We also work with employers to provide workplace menopause support, helping companies create menopause-friendly policies and offering direct services to employees who need them. If your organisation is interested in supporting menopausal employees, please explore our corporate menopause treatment services.